Extracorporeal cytokine adsorption for treating severe refractory cytokine release syndrome (CRS)

被引：0
|
作者：
Florent Wallet
Emmanuel Bachy
Olivia Vassal
Arnaud Friggeri
Julien Bohe
Lorna Garnier
Gilles Salles
Bernard Allaouchiche
机构：
[1] Lyon Sud Teaching hospital,Medical Intensive Care Unit, Hospices Civils de Lyon
[2] University of Lyon,Department of Hematology, Hospices Civils de Lyon
[3] Claude Bernard Lyon 1 University,Laboratory of Biology and Immunology, Hospices Civils de Lyon
[4] Lyon Sud Teaching hospital,undefined
[5] Lyon Sud Teaching hospital,undefined
来源：
Bone Marrow Transplantation | 2020年 / 55卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2052 / 2055
页数：3
相关论文
共 50 条
  • [21] ANV-419Cytokine release syndrome (CRS) in the form of hypotension, fever, chills and CRS: 2 case reports
    Reactions Weekly, 2024, 2028 (1) : 65 - 65
  • [22] Cytokine adsorption during extracorporeal membrane oxygenation
    Supady, Alexander
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2023, 118 (06) : 499 - 501
  • [23] Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Relapsed/Refractory (R/R) CLL
    Porter, David L.
    Lacey, Simon F.
    Hwang, Wei-Ting
    Shaw, Pamela
    Frey, Noelle V.
    Chew, Anne
    Chen, Fang
    Kalos, Michael
    Gonzalez, Vanessa
    Marcucci, Katherine T.
    Maude, Shannon L.
    Melenhorst, Jan J.
    Litchman, Manuel
    Teachey, David T.
    Shen, Angela
    Quintas-Cardamas, Alfonso
    Wood, Patricia A.
    Levine, Bruce L.
    June, Carl H.
    Grupp, Stephan A.
    BLOOD, 2014, 124 (21)
  • [24] Risk of Cytokine Release Syndrome (CRS) with glofitamab is predicted by an updated model with a potential clinical application
    Subkleve, M.
    Komanduri, K. V.
    Belousov, A.
    Dixon, M.
    Relf, J.
    Tandon, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 207 - 208
  • [25] STAT CYTOKINE RELEASE SYNDROME
    Dickman, Erin
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2020, 24 (04) : 456 - 456
  • [26] Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm
    Gonzalez-Rubio, Jesus
    Navarro-Lopez, Carmen
    Lopez-Najera, Elena
    Lopez-Najera, Ana
    Jimenez-Diaz, Lydia
    Navarro-Lopez, Juan D.
    Najera, Alberto
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [27] Understanding cytokine release syndrome
    Goedel, Philipp
    Shimabukuro-Vornhagen, Alexander
    von Bergwelt-Baildon, Michael
    INTENSIVE CARE MEDICINE, 2018, 44 (03) : 371 - 373
  • [28] Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
    Scott, Sara A.
    Marin, Ellen M.
    Maples, Kathryn T.
    Joseph, Nisha S.
    Hofmeister, Craig C.
    Gupta, Vikas A.
    Dhodapkar, Madhav V.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Nooka, Ajay K.
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [29] Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab: A single-center experience
    Sara A. Scott
    Ellen M. Marin
    Kathryn T. Maples
    Nisha S. Joseph
    Craig C. Hofmeister
    Vikas A. Gupta
    Madhav V. Dhodapkar
    Jonathan L. Kaufman
    Sagar Lonial
    Ajay K. Nooka
    Blood Cancer Journal, 13
  • [30] BelimumabSeizures and cytokine release syndrome
    Reactions Weekly, 2024, 2003 (1) : 164 - 164
12345